Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$42,286,034
in 14 filings, $42.3M under 10b5-1 plans

Net −$42,286,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-10 Patterson Sandra SVP, Controllership Exercise or conversion · Restricted Stock Unit −1,952 9,875
2025-03-10 Berger Dietmar Chief Medical Officer Grant or award · Restricted Stock Unit +8,530 57,505
2025-03-10 Berger Dietmar Chief Medical Officer Grant or award · Non-qualified Stock Option (Right to Buy) +37,710 37,710
2025-02-18 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −2,500 $104.09 $260K 169,061
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion 10b5-1 +77,691 $63.91 $5.0M 248,914
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion 10b5-1 +26,175 $57.92 $1.5M 275,089
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion 10b5-1 +15,600 $80.72 $1.3M 290,689
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion 10b5-1 +18,210 $83.49 $1.5M 308,899
2025-02-12 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −137,676 $102.22 $14.1M 171,223
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −77,691 17,929
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −26,175 78,515
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −15,600 0
2025-02-12 Dickinson Andrew D Chief Financial Officer Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −18,210 0
2025-02-04 Patterson Sandra SVP, Controllership Grant or award +709 37,787
2025-02-04 Telman Deborah H EVP, Corporate Affairs & GC Grant or award +12,371 34,011
2025-02-04 O'Day Daniel Patrick Chairman & CEO Grant or award +60,031 561,559
2025-02-04 O'Day Daniel Patrick Chairman & CEO Grant or award +164,473 726,032
2025-02-04 O'Day Daniel Patrick Chairman & CEO Shares withheld for taxes −108,156 $97.99 $10.6M 617,876
2025-02-04 Mercier Johanna Chief Commercial Officer Grant or award +19,793 94,933
2025-02-04 Mercier Johanna Chief Commercial Officer Grant or award +70,712 165,645

Page 20 of 43 · 857 trades